Curcumin Enhances the Anti-Cancer Efficacy of CDK4/6 Inhibitors in Prostate Cancer
CONCLUSIONS: The findings of this study suggested that the combination of CDK4/6 inhibitor and curcumin may have clinical implications for the treatment of PCa.PMID:38374014 | DOI:10.56434/j.arch.esp.urol.20247701.8
Source: Archivos Espanoles de Urologia - Category: Urology & Nephrology Authors: Huandong Zhao Ruimin Ding Jiarui Han Source Type: research
More News: Cancer | Cancer & Oncology | Genetics | Nanotechnology | Prostate Cancer | Study | Turmeric | Urology & Nephrology